Opportunity ID: 343369

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HD-23-003
Funding Opportunity Title: Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 06, 2022
Last Updated Date: Sep 06, 2022
Original Closing Date for Applications: Nov 30, 2022
Current Closing Date for Applications: Nov 30, 2022
Archive Date: Jan 05, 2023
Estimated Total Program Funding:
Award Ceiling: $750,000
Award Floor:

Eligibility

Eligible Applicants: State governments
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Special district governments
Private institutions of higher education
City or township governments
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement invites applications to form Transporter Elucidation Centers (TECs) as part of a Transporter Elucidation Network (TEN). TECs funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will address key knowledge gaps in functional transport of nutrients and drugs to the developing fetus and infant through a focus on human placenta, lactating mammary gland, and developing gut. Such projects may necessitate deorphanization and characterization of understudied transporters and functional variants. The NICHD-funded TECs will work together to generate knowledge and resources that will be shared with the broader research community to advance our understanding of nutrient, drug, and supplement transport to the developing fetus and infant.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-23-003.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 343369 Full Announcement-RFA-HD-23-003 -> RFA-HD-23-003-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00276654 Oct 30, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00278464 Nov 15, 2022 Nov 30, 2022 View

Package 1

Mandatory forms

343369 RR_SF424_5_0-5.0.pdf

343369 PHS398_CoverPageSupplement_5_0-5.0.pdf

343369 RR_OtherProjectInfo_1_4-1.4.pdf

343369 PerformanceSite_4_0-4.0.pdf

343369 RR_KeyPersonExpanded_4_0-4.0.pdf

343369 RR_Budget_3_0-3.0.pdf

343369 PHS398_ResearchPlan_4_0-4.0.pdf

343369 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343369 RR_SubawardBudget30_3_0-3.0.pdf

343369 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

343369 RR_SF424_5_0-5.0.pdf

343369 PHS398_CoverPageSupplement_5_0-5.0.pdf

343369 RR_OtherProjectInfo_1_4-1.4.pdf

343369 PerformanceSite_4_0-4.0.pdf

343369 RR_KeyPersonExpanded_4_0-4.0.pdf

343369 RR_Budget_3_0-3.0.pdf

343369 PHS398_ResearchPlan_5_0-5.0.pdf

343369 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

343369 RR_SubawardBudget30_3_0-3.0.pdf

343369 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T16:33:02-05:00

Share This Post, Choose Your Platform!

About the Author: